Jazz Pharmaceuticals plc ( JAZZ) Q4 2025 Earnings Call February 24, 2026 4:30 PM EST Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings ...

According to MarketsandMarkets™, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 ...

According to MarketsandMarkets, the global pharmaceutical manufacturing equipment market is projected to reach USD 21.24 billion in 2026 and ...

This clinical-stage biotech develops targeted cancer therapies, leveraging bispecific antibodies and strategic industry partnerships.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced financial results for the full year and fourth quarter of 2025 and provided financial guidance for 2026.

Jazz Pharmaceuticals is positioned for long-term value creation, with a relief rally following Q4 2025 results and the 2026 ...

Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...

BARCELONA, Feb 26 (Reuters) - Spanish drugmaker Grifols reported on Thursday a net profit of 402 million euros ($473.96 ...

Cardinal Health CAH-0.99%decrease; red down pointing triangle once again raised its outlook for the year, citing broad-based growth across its business and continued momentum in pharmaceutical ...

GE HealthCare (Nasdaq: GEHC) today announced a 10-year Care Alliance enterprise collaboration with UCSF Health.

The Trump administration is delaying the release of TrumpRx, an online platform that lets people buy prescription drugs directly from pharmaceutical companies at a discount, according to Politico.